Loading...
XNAS
NAII
Market cap7mUSD
Oct 08, Last price  
1.15USD
1D
-11.24%
1Q
-48.65%
Jan 2017
-89.87%
Name

Natural Alternatives International Inc

Chart & performance

D1W1MN
XNAS:NAII chart
P/E
—
P/S
0.05
EPS
—
Div yield, %
—
Shrs. gr., 5y
-1.13%
Rev. gr., 5y
-4.56%
Revenues
141m
+8.85%
97,128,00081,755,00073,919,00065,553,00055,882,00072,822,00062,797,00073,942,00079,508,000114,201,000121,946,000132,437,000138,290,000118,876,000178,520,000170,966,000154,015,000113,796,000129,860,000141,353,000
Net income
-21m
L+52.45%
-5,285,000-371,000-4,080,0004,127,0005,086,0004,158,0001,570,0001,994,0003,346,0009,546,0007,235,0005,051,0006,541,000-1,645,00010,768,00010,712,0002,522,000-7,217,000-13,575,000-20,695,000
CFO
-9m
L
15,058,0002,688,0004,887,0007,088,0009,087,0001,730,0004,470,0005,347,0002,678,0009,285,00014,137,0001,833,0006,564,0003,691,00020,806,00011,866,0007,019,000-1,497,0005,932,000-8,916,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.

Related entities

Subsidiaries
NAIE NATURAL ALTERNATIVES INTERNATIONAL EUROPE SA

Key people

Mark A. LeDoux
Chairman of the Board of Directors, Chief Executive Officer · since 2001
Michael E. Fortin
Chief Financial Officer · since 2015
Kenneth Eugene Wolf
President, Chief Operating Officer, Treasurer, Secretary · since 2015
Independent Director · since 2000
Alan G. Dunn
Independent Director · since 2004
Independent Director · since 2004
Lee G. Weldon
Independent Director · since 1992
IPO date
Jan 13, 1997
Employees
356
Domiciled in
US
Incorporated in
US
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
1535 Faraday Ave
Carlsbad, CA 92008
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT